ADHD has evolved from being primarily recognized as a childhood disorder to a significant concern among adults, with a notable increase in awareness campaigns and clinics offering diagnoses.

According to a recent CDC report, nearly half of the estimated 15.5 million adults in the U.S. diagnosed with ADHD received their diagnosis in adulthood.

Discussions on neurodiversity are gaining traction, emphasizing the spectrum of cognitive differences, including ADHD, and the unique functioning of each individual's brain.

The modern attention economy, characterized by constant distractions, may exacerbate ADHD-like symptoms in individuals who previously showed no signs of the disorder.

In response to the rising demand for adult ADHD diagnoses, the National Health Service in Britain has established a new taskforce to manage the influx of requests for treatment.

The trend of ADHD diagnoses has been on the rise since the 1990s, with the CDC's 2023 sample indicating that half of adults diagnosed did so in adulthood.

The pandemic has led to relaxed regulations by the DEA, facilitating easier access to ADHD medications through telemedicine, significantly impacting treatment availability.

Telemedicine has become a crucial method for managing ADHD, with around 50% of diagnosed adults utilizing these services, although many face medication refill issues due to shortages.

Concerns have emerged regarding the over-prescription of ADHD medications through telehealth services, particularly with allegations against the company Done for inappropriate prescription practices.

The validity of adult-onset ADHD is under scrutiny, with evidence suggesting that many adults self-diagnosing may actually be neurotypical.

Complications arise in diagnosing ADHD due to overlapping symptoms with burnout, such as lack of motivation and distraction, leading to debates on whether ADHD is overdiagnosed or underdiagnosed.

The discussion around ADHD diagnosis also highlights disparities, with certain demographic groups, including African American and Latinx children and women, reportedly underdiagnosed.